Opposing effects of curcuminoids on serum stimulated and unstimulated angiogenic response

Journal of Cellular Physiology

Volumn 215, Issue 1, 2008, Pages 251-264

  Kiran, M S ^a   Sameer Kumar, V B ^a   Viji, R I ^a   Sherin, G T ^a   Rajasekharan, K N ^a   Sudhakaran, P R ^a  

^a UNIVERSITY OF KERALA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; BIOCHEMICAL MARKER; CD31 ANTIGEN; CURCUMIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 2; ANGIOGENIC FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEINASE ACTIVATED RECEPTOR; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL ACTIVITY; CAPILLARY; CELL CULTURE; CELL STIMULATION; CHORIOALLANTOIS; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MICROENVIRONMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SUPPLEMENTATION; UMBILICAL VEIN; VASCULAR RING; ANIMAL; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SERUM; SPRAGUE DAWLEY RAT;

RATTUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTIGENS, CD31; CELLS, CULTURED; CURCUMIN; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROTEINASE-ACTIVATED; SERUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 39149117744     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21307     Document Type: Article

References (54)

1. Aggarwal BB, Kumar A, Aggarwal MS, Shishodia S. 2005. Curcumin derived from turmeric (Curcuma longa): A spice for all seasons. In: Preuss H, editor. Phytopharmaceuticals in cancer chemoprevention. Boca Raton: CRC Press. pp 349-387.
2. Araki S, Simada Y, Kaji K, Hayashi H. 1990. Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cells. Biochem Biophys Res Commun 172:1081-1085.
3. Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Huang MT, Fisher C, Flynn E, Byers HR. 1998. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 4:376-383.
4. Babu KVD, Rajasekharan KN. 1994. Simplified conditions for the synthesis of curcumin 1 and other curcuminoids. Org Prep Proc Intl 26:674-677.
5. Bogatcheva NV, Dudek SM, Garcia JGN, Verin AD. 2003. Mitogen activated protein kinases in endothelial pathophysiology. J Invest Med 51:341-352.
6. Boyd P, Doyle J, Gee E, Pallan S, Haas TL. 2005. MAPK signaling regulates endothelial cell assembly into networks and expression of MT1-MMP and MMP-2. Am J Physiol Cell Physiol 288:659-668.
7. Brooks PC, Montgomery AM, Cheresh DA. 1999. Use of the 10-day-old chick embryo model for studying angiogenesis. Methods Mol Biol 129:257-269.
8. Cardenas C, Quesada AR, Medina MA. 2004. Effects of ursolic acid on different steps of the angiogenic process. Biochem Biophys Res Commun 320:402-408.
9. Carmeliet P. 2003. Angiogenesis in health and disease. Nat Med 9:653-660.
10. Deregibus MC, Buttiglieri S, Russo S, Bussolati B, Camussi G. 2003. CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis. J Biol Chem 278:18008-18014.
11. Dulak J. 2005. Nutraceuticals as anti-angiogenic agents: Hopes and reality. J Physiol Pharmacol 56:51-69.
12. Engvall E, Perlman P. 1971. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 8:871-874.
13. Estabrook RW, Williamson JR, Frenkel R, Maitra PK. 1967. The fluorometric determination of mitochondrial adenine and pyridine nucleotides. In: Estabrook RW, Pullman ME, editors. Methods in enzymology. New York: Academic Press. pp 474-482.
14. Gopinath D, Ahmed MR, Gomathi K, Chitra K, Sehgal PK, Jayakumar R. 2004. Dermal wound healing processes with curcumin incorporated collagen films. Biomaterials 25:1911-1917.
15. Gratton JP, Morales-Ruiz M, Kureishi Y, Fulton D, Walsh K, Sessa WC. 2001. Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem 276:30359-30365.
16. Gupta B, Ghosh B. 1999. Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. Int J Immunopharmacol 21:745-757.
17. Gururaj AE, Belakavadi M, Venkatesh DA, Marme D, Salimath BP. 2002. Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun 297:934-942.
18. Hahm ER, Gho YS, Park S, Park C, Kim KW, Yang CH. 2004. Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis. Biochem Biophys Res Commun 321:337-344.
19. Harfouche R, Gratton JP, Yancopoulos GD, Noseda M, Karsan A, Hussain SN. 2003. Angiopoietin-1 activates both anti- and proapoptotic mitogen-activated protein kinases. FASEB J 17:1523-1525.
20. Huang TS, Kuo ML, Lin JK, Hsieh JS. 1995. A labile hyperphosphorylated c-Fos protein is induced in mouse fibroblast cells treated with a combination of phorbol ester and antitumor promoter curcumin. Cancer Lett 96:1-7.
21. Ivana Scovassi A, Diederich M. 2004. Modulation of poly (ADP-ribosylation) in apoptotic cells. Biochem Pharmacol 68:1041-1047.
22. Jaffe EA, Nachman RL, Becker CG, Minick CR. 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745-2756.
23. Jagetia GC, Rajanikant GK. 2004. Role of curcumin, a naturally occurring phenolic compound of turmeric in accelerating the repair of excision wound, in mice whole-body exposed to various doses of gamma-radiation. J Surg Res 120:127-138.
24. Jagetia GC, Rajanikant GK. 2005. Curcumin treatment enhances the repair and regeneration of wounds in mice exposed to hemibody gamma-irradiation. Plast Reconstr Surg 115:515-528.
25. Joe B, Vijaykumar M, Lokesh BR. 2004. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 44:97-111.
26. Karunagaran D, Rashmi R, Kumar TR. 2005. Induction of curcumin and its implications for cancer therapy. Curr Cancer Drug Targets 5:117-129.
27. Kim BS, Chen J, Weinstein T, Noiri E, Goligorsky MS. 2002. VEGF expression in hypoxia and hyperglycemia: Reciprocal effect on branching angiogenesis in epithelial-endothelial co-cultures. J Am Soc Nephrol 13:2027-2036.
28. Kiran MS, Kumar VBS, Viji RI, Sudhakaran PR. 2006. Temporal relationship between MMP production and angiogenic process in HUVECs. Cell Biol Int 30:704-713.
29. Kraling BM, Razon MJ, Boon LM, Zurakowski D, Seachord C, Darveau RP, Mulliken JB, Corless CL, Bischoff J. 1996. E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Pathol 148:1181-1191.
30. Kumar VBS, Viji RI, Kiran MS, Sudhakaran PR. 2007. Endothelial cell response to lactate: Implication of PAR modification of VEGF. J Cell Physiol 211:477-485.
31. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
32. Leu TH, Maa MC. 2002. The molecular mechanisms for the antitumorigenic effect of curcumin. Curr Med Chem Anticancer Agents 2:357-370.
33. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
34. Mandriota SJ, Pepper MS. 1997. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J Cell Sci 110:2293-2302.
35. Mohan R, Sivak J, Ashton P, Russo LA, Pham BQ, Kasahara N, Raizman MB, Fini ME. 2000. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem 275:10405-10412.
36. Munoz-Chapulia R, Quesada AR, Medina AM. 2004. Angiogenesis and signal transduction in endothelial cells. Cell Mol Life Sci 61:2224-2243.
37. Nicosia RF, Ottinetti A. 1990. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 63:115-122.
38. Nicosia RF, Villaschi S, Smith M. 1994. Isolation and characterization of vasoformative endothelial cells from the rat aorta. In Vitro Cell Dev Biol Anim 30A:394-399.
39. Pollman MJ, Naumovski L, Gibbons GH. 1999. Vascular cell apoptosis: Cell type-specific modulation by transforminggrowth factor-beta I in endothelial cells versus smooth muscle cells. Circulation 99:2019-2026.
40. Risau W. 1997. Mechanisms of angiogenesis. Nature 386:671-674.
41. Rousseau S, Houle F, Landry J, Huot J. 1997. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15:2169-2177.
42. Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, Limtrakul P, Badmaev V, Aggarwal BB. 2007. Curcumin, demethoxycurcumin, bisdemothoxycurcumin, tetrahydrocurcumin, and turmerones differentially regulate anti-inflammatory and antiproliferative responses through a ROS-independent mechanism. Carcinogenesis 28:1765-1773.
43. Shim JS, Kim DH, Jung HJ, Kim JH, Lim D, Lee SK, Kim KW, Ahn JW, Yoo JS, Rho JR, Shin J, Kwon HJ. 2002. Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation. Bioorg Med Chem 10:2987-2992.
44. Shiojima I, Walsh K. 2002. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90:1243-1250.
45. Sidhu GS, Singh AK, Thaloor D, Banaudha KK, Patnaik GK, Srimal RC, Maheshwari RK. 1998. Enhancement of wound healing by curcumin in animals. Wound Repair Regen 6: 167-177.
46. Sidhu GS, Mani H, Gaddipati JP, Singh AK, Seth P, Banaudha KK, Patnaik GK, Maheshwari RK. 1999. Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair Regen 7:362-374.
47. Singh S, Aggarwal BB. 1995. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem 270:24995-25000.
48. Singh AK, Sidhu GS, Deepa T, Maheshwari RK. 1996. Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell. Cancer Lett 107:109-115.
49. Sladowski D, Steer SJ, Clothier RH, Balls M. 1993. An improved MTT assay. J Immunol Methods 157:203-207.
50. Stoltz RA, Abraham NG, Laniado-Schwartzman M. 1996. The role of NF-kappaB in the angiogenic response of coronary microvessel endothelial cells. Proc Natl Acad Sci USA 93:2832-2837.
51. Thaloor D, Singh AK, Sidhu GS, Prasad PV, Kleinman HK, Maheshwari RK. 1998. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ 9:305-312.
52. Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from Polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
53. Yang S, Graham J, Kahn JW, Schwartz EA, Gerritsen ME. 1999. Functional roles of PECAM-1 (CD 31) and VE Cadherin (CD144) in tube assembly and lumen formation in three dimensional collagen gels. Am J Pathol 155:887-895.
54. Zabel DD, Feng JJ, Scheuenstuhl H, Hunt TK, Hussain MZ. 1996. Lactate stimulation of macrophage-derived angiogenic activity is associated with inhibition of Poly (ADP-ribose) synthesis. Lab Invest 74:644-649.